Looking for a coach? Sign up for a coaching consulting call today!
Oct. 12, 2023

Pediatric hematology and transfusion medicine with Dr. Stella Chou

Pediatric hematology and transfusion medicine with Dr. Stella Chou
The player is loading ...
Clinician Researcher

Dr. Stella Chou is a distinguished clinician scientist specializing in pediatric hematology and transfusion medicine. In today's episode, Dr. Chou shares her remarkable journey to become a clinician scientist. She emphasizes the importance of recognizing and seizing opportunities for research collaboration.

Key Points Discussed:

  • Dr. Chou's research interests in pediatric hematology and transfusion medicine.
  • The influence of family on her attitude toward seizing opportunities.
  • The significance of supportive environments.
  • The importance of collaboration.
  • The need to take small steps.

Links and Resources Mentioned:

Call to Action: As a listener, you can take the following actions:

  1. For more insightful episodes, subscribe to the Clinician Researcher Podcast.
  2. To learn more about the topics discussed, explore the resources and links mentioned.
  3. Share this episode with colleagues and friends.
Transcript

1 00:00:00,000 --> 00:00:05,860 Welcome to the Clinician Researcher podcast, where academic clinicians learn the skills 2 00:00:05,860 --> 00:00:11,260 to build their own research program, whether or not they have a mentor. 3 00:00:11,260 --> 00:00:17,340 As clinicians, we spend a decade or more as trainees learning to take care of patients. 4 00:00:17,340 --> 00:00:22,380 When we finally start our careers, we want to build research programs, but then we find 5 00:00:22,380 --> 00:00:27,780 that our years of clinical training did not adequately prepare us to lead our research 6 00:00:27,780 --> 00:00:29,200 program. 7 00:00:29,200 --> 00:00:35,480 Through no fault of our own, we struggle to find mentors, and when we can't, we quit. 8 00:00:35,480 --> 00:00:40,580 However, clinicians hold the keys to the greatest research breakthroughs. 9 00:00:40,580 --> 00:00:46,200 For this reason, the Clinician Researcher podcast exists to give academic clinicians 10 00:00:46,200 --> 00:00:51,800 the tools to build their own research program, whether or not they have a mentor. 11 00:00:51,800 --> 00:01:01,100 Now introducing your host, Toyosi Onwuemene. 12 00:01:01,100 --> 00:01:03,640 Welcome to the Clinician Researcher podcast. 13 00:01:03,640 --> 00:01:06,860 I'm your host, Toyosi Onwuemene, and it is a pleasure to be here today. 14 00:01:06,860 --> 00:01:11,260 I have an outstanding clinician scientist to introduce to you today. 15 00:01:11,260 --> 00:01:13,520 Her name is Dr. Stella Chou. 16 00:01:13,520 --> 00:01:15,980 Stella, welcome to the show. 17 00:01:15,980 --> 00:01:16,980 Thank you. 18 00:01:16,980 --> 00:01:21,660 So, Stella, for our audience, would you please introduce yourself, especially in the context 19 00:01:21,660 --> 00:01:26,260 of how you came to be doing this thing, where you're a clinician and a scientist at the 20 00:01:26,260 --> 00:01:27,260 same time? 21 00:01:27,260 --> 00:01:28,260 Sure. 22 00:01:28,260 --> 00:01:35,620 So, I'm a pediatric hematologist by training, who then got a fellowship training in transfusion 23 00:01:35,620 --> 00:01:36,620 medicine. 24 00:01:36,620 --> 00:01:43,580 So, I practice both non-malignant hematology and transfusion medicine, primarily in pediatrics, 25 00:01:43,580 --> 00:01:46,900 but I do care for young adults as well. 26 00:01:46,900 --> 00:01:50,660 And I think really how I got here was pretty circuitous. 27 00:01:50,660 --> 00:01:57,580 I went to med school because I wanted to be a pediatrician, and during med school, I became 28 00:01:57,580 --> 00:02:00,940 interested actually in pediatric oncology. 29 00:02:00,940 --> 00:02:08,460 But when I came to CHUMP, I was exposed to all aspects of pediatric hematology that actually 30 00:02:08,460 --> 00:02:12,380 piqued my interests in a different way. 31 00:02:12,380 --> 00:02:19,260 And probably the reason why I ended up in hematology versus oncology, honestly, is because 32 00:02:19,260 --> 00:02:25,500 for my second year during fellowship, I chose to join the lab of Dr. Mitchell Weiss, who's 33 00:02:25,500 --> 00:02:28,300 now at St. Jude's. 34 00:02:28,300 --> 00:02:34,540 And I joined his lab to study a disease that affects children with Down syndrome. 35 00:02:34,540 --> 00:02:41,060 So, patients with trisomy 21 who get either transient abnormal myelopoiesis or myeloid 36 00:02:41,060 --> 00:02:42,620 leukemia. 37 00:02:42,620 --> 00:02:49,380 And at first, it really combined my interest in hematopoiesis as well as oncology. 38 00:02:49,380 --> 00:02:57,340 But I think in working with Mitch, I just leaned more and more towards hematology. 39 00:02:57,340 --> 00:03:03,260 And after I completed my fellowship, I ended up doing a transfusion medicine fellowship 40 00:03:03,260 --> 00:03:04,540 a few years later. 41 00:03:04,540 --> 00:03:10,060 And again, that was something that just was an opportunity that came my way, and I decided 42 00:03:10,060 --> 00:03:16,820 to take it and met a number of people in the transfusion medicine community who sort of 43 00:03:16,820 --> 00:03:19,580 helped me make that decision. 44 00:03:19,580 --> 00:03:26,140 And since then, I have primarily worked more in the hematology, transfusion, medicine space, 45 00:03:26,140 --> 00:03:32,100 but the project I came to do as a second year fellow, I guess now it's almost 20 years ago 46 00:03:32,100 --> 00:03:34,240 when I joined Mitch's lab. 47 00:03:34,240 --> 00:03:40,540 We still work on that problem in my own lab, but we have much better tools two decades 48 00:03:40,540 --> 00:03:41,540 later, I think. 49 00:03:41,540 --> 00:03:46,380 But it's interesting to look back and say, for instance, grants that I wrote as a fellow, 50 00:03:46,380 --> 00:03:48,860 what were the questions we were asking and trying to answer? 51 00:03:48,860 --> 00:03:54,020 And some of those questions are still unanswered and we're still trying to answer, which is 52 00:03:54,020 --> 00:03:55,900 part of science. 53 00:03:55,900 --> 00:04:01,820 But I guess my point is that I think I ended up here because of just different people in 54 00:04:01,820 --> 00:04:09,220 my career and then the different opportunities that came my way being at Chopin and Penn. 55 00:04:09,220 --> 00:04:10,220 Awesome. 56 00:04:10,220 --> 00:04:11,220 Thank you for sharing. 57 00:04:11,220 --> 00:04:18,900 Now, I see in your story, someone who was open to opportunities and someone who recognized 58 00:04:18,900 --> 00:04:20,820 and took opportunities. 59 00:04:20,820 --> 00:04:27,300 Can you tell me about what it was in your makeup, either your prior history or family 60 00:04:27,300 --> 00:04:32,620 history, your experiences that allowed you to be that kind of person who just kind of 61 00:04:32,620 --> 00:04:36,260 took opportunities as they came? 62 00:04:36,260 --> 00:04:38,340 I think probably it's how I was raised. 63 00:04:38,340 --> 00:04:40,620 My parents were both immigrants to the US. 64 00:04:40,620 --> 00:04:46,260 I think people oftentimes look at me now and just expect that I had every opportunity in 65 00:04:46,260 --> 00:04:53,420 my lifetime, but my grandfather actually immigrated here and was a magician and then ended up having 66 00:04:53,420 --> 00:04:59,900 his own laundry mat business, which provided him with the means to then end up buying real 67 00:04:59,900 --> 00:05:03,020 estate and doing very well for himself. 68 00:05:03,020 --> 00:05:09,540 But both my parents do not hold college degrees and still I'm actually the first generation 69 00:05:09,540 --> 00:05:14,140 of my family to have a college degree, which you can imagine is very different, especially 70 00:05:14,140 --> 00:05:20,540 now as my own daughter is applying for college for this next fall. 71 00:05:20,540 --> 00:05:24,260 It's the types of applications and the types of opportunities she has compared to what 72 00:05:24,260 --> 00:05:25,260 I have. 73 00:05:25,260 --> 00:05:30,780 But I think what my parents always instilled in me was that opportunities are in front 74 00:05:30,780 --> 00:05:31,780 of you. 75 00:05:31,780 --> 00:05:37,100 You just have to recognize when something's an opportunity and take it. 76 00:05:37,100 --> 00:05:40,860 And I think their opportunities were very different than the opportunities that I had 77 00:05:40,860 --> 00:05:41,860 to take. 78 00:05:41,860 --> 00:05:48,100 But I think nonetheless, it sort of was a lesson in life that I think my parents imparted 79 00:05:48,100 --> 00:05:52,500 on myself and my four siblings just by their actions. 80 00:05:52,500 --> 00:05:54,780 They never really said those words to us. 81 00:05:54,780 --> 00:06:00,180 I think it was really by their actions and how they just supported us. 82 00:06:00,180 --> 00:06:06,380 And they always tried to do everything for us that would allow us to have every opportunity, 83 00:06:06,380 --> 00:06:12,480 even though we didn't always have all the means that other people in my school had. 84 00:06:12,480 --> 00:06:17,300 So I think that's probably where it's most grounded from. 85 00:06:17,300 --> 00:06:18,300 Thank you for sharing that. 86 00:06:18,300 --> 00:06:25,100 I mean, I see just it sounds like a family culture of looking for opportunity, recognizing 87 00:06:25,100 --> 00:06:29,500 it and seizing it when it comes, but also being prepared for the opportunity when it 88 00:06:29,500 --> 00:06:30,500 arises. 89 00:06:30,500 --> 00:06:37,860 And I think I've been really fortunate to be a place where people are very supportive. 90 00:06:37,860 --> 00:06:42,940 And I think that helps because you can try something and if you fail, they're fine with 91 00:06:42,940 --> 00:06:46,340 that and you can try to do something else. 92 00:06:46,340 --> 00:06:54,660 And so I think always knowing that you can try things and if you're willing to take a 93 00:06:54,660 --> 00:07:01,220 little bit of failure or you're willing to not have the expectation always that you will 94 00:07:01,220 --> 00:07:04,520 succeed in the way you think you're going to succeed, because I think that's something 95 00:07:04,520 --> 00:07:12,260 else that I learned along the way, is what do we consider a success and what you might 96 00:07:12,260 --> 00:07:17,820 think of as success might be different from who you report to per se. 97 00:07:17,820 --> 00:07:24,340 But in the end, I think that it really matters what you think is success and what you think 98 00:07:24,340 --> 00:07:28,260 brings meaning to what you do when you come to work every day. 99 00:07:28,260 --> 00:07:29,260 Wow. 100 00:07:29,260 --> 00:07:33,580 You said two things that are really amazing and I just want to come back to. 101 00:07:33,580 --> 00:07:39,380 So first you talk about failure and not being afraid to fail and the importance of having 102 00:07:39,380 --> 00:07:43,860 environments that allow you to do that so that you don't feel as if you're taking a 103 00:07:43,860 --> 00:07:48,620 risk it's an unalterable risk or you can't change direction. 104 00:07:48,620 --> 00:07:53,540 I want you to speak a little bit more about what that looks like, do you think, in today's 105 00:07:53,540 --> 00:07:58,860 environments for clinicians who are trying to make this transition to research, do we 106 00:07:58,860 --> 00:08:02,220 have the same kinds of supportive environments today? 107 00:08:02,220 --> 00:08:04,020 I think so. 108 00:08:04,020 --> 00:08:10,860 I think actually over the years there's been more and more support to take an idea, make 109 00:08:10,860 --> 00:08:17,700 it a question, write it in a grant, hopefully get funded, and then bring it to realization. 110 00:08:17,700 --> 00:08:24,780 I think there's many routes that you might take and some of them are certainly baby steps 111 00:08:24,780 --> 00:08:27,940 whereas other things might seem like they are riskier. 112 00:08:27,940 --> 00:08:30,000 I'm really going to try this. 113 00:08:30,000 --> 00:08:39,180 But I think if you have the attitude that you can make it happen by garnering the right 114 00:08:39,180 --> 00:08:40,940 people to help you do it. 115 00:08:40,940 --> 00:08:43,940 So I think we never do anything by ourselves. 116 00:08:43,940 --> 00:08:49,220 We get the help from the trainees who are in our lab or the research assistants or the 117 00:08:49,220 --> 00:08:57,860 research coordinators who we work with to all the people who help get things done. 118 00:08:57,860 --> 00:09:05,900 The core labs, our admins, our sponsored projects office, there's so many people who are involved. 119 00:09:05,900 --> 00:09:10,980 And then also the people that you look to as mentors and sponsors. 120 00:09:10,980 --> 00:09:17,020 I think you know that you have so many different places where you might be able to get help. 121 00:09:17,020 --> 00:09:20,140 But I do think people is a major facet. 122 00:09:20,140 --> 00:09:29,700 I feel like if I find that there's a challenging problem, I think I have the mindset of, well, 123 00:09:29,700 --> 00:09:35,260 let me find someone who probably can solve this problem and see if I can work with them. 124 00:09:35,260 --> 00:09:37,620 And I think sometimes you have to choose wisely, right? 125 00:09:37,620 --> 00:09:41,540 So sometimes you don't go to like be the expert. 126 00:09:41,540 --> 00:09:48,020 You go to someone who, you know, knows the field well, but will also have the time and 127 00:09:48,020 --> 00:09:51,180 the space to work with you. 128 00:09:51,180 --> 00:09:57,140 And I think most things that we do end up really being a team effort. 129 00:09:57,140 --> 00:10:04,980 So I think nowadays, more than even when I started out, collaboration is really something 130 00:10:04,980 --> 00:10:12,580 that everybody supports and that institutions have found ways to allow for collaboration. 131 00:10:12,580 --> 00:10:17,620 So either they have small pilot grants for that or they have seminar series that try 132 00:10:17,620 --> 00:10:19,780 to bring different groups together. 133 00:10:19,780 --> 00:10:24,780 So then you meet people on a regular basis that you might not have had that interest 134 00:10:24,780 --> 00:10:26,900 group not have come together. 135 00:10:26,900 --> 00:10:33,460 And then certainly it seems like most funding agencies do support collaborative efforts. 136 00:10:33,460 --> 00:10:36,280 So I think that's a big piece of it. 137 00:10:36,280 --> 00:10:40,100 And I also think there is the element of being realistic. 138 00:10:40,100 --> 00:10:48,020 So for instance, when I started doing the work that has been done really in collaboration 139 00:10:48,020 --> 00:10:54,540 with New York Blood Center, with Connie Westoff and Sydney DeVege, looking at using molecular 140 00:10:54,540 --> 00:11:00,940 typing and doing high resolution typing at the RH locus to see how we could better match 141 00:11:00,940 --> 00:11:05,480 patients with sickle cell disease to their donors. 142 00:11:05,480 --> 00:11:10,580 I think we took baby steps, like first we showed that it was important. 143 00:11:10,580 --> 00:11:17,260 And now currently we have pilot clinical trials in a small subset of patients who were actually 144 00:11:17,260 --> 00:11:20,180 providing genotype matched blood. 145 00:11:20,180 --> 00:11:24,060 And we knew that logistically we had to get blood from the New York Blood Center, which 146 00:11:24,060 --> 00:11:28,900 is at a depot in Long Island City to Philadelphia. 147 00:11:28,900 --> 00:11:33,800 We know that patients reschedule or patients have other reasons why they might not come 148 00:11:33,800 --> 00:11:39,020 that particular day, or if we have something that shows up in their antibody screen that 149 00:11:39,020 --> 00:11:41,620 day and we might have to change course a little bit. 150 00:11:41,620 --> 00:11:44,380 So really we started out as a pilot study. 151 00:11:44,380 --> 00:11:49,780 And I think the next step will be to extend that study still as a single institution study 152 00:11:49,780 --> 00:11:55,780 before we can take it on to the next step, which is a multi-institutional study. 153 00:11:55,780 --> 00:11:59,800 But to do that will require even more collaboration. 154 00:11:59,800 --> 00:12:03,620 So we're going to need other blood centers aside from New York Blood Center being involved. 155 00:12:03,620 --> 00:12:11,020 We'll need multiple institutions who would be able and willing to participate. 156 00:12:11,020 --> 00:12:16,600 And there's probably a lot of other facets that we would have to figure out in terms 157 00:12:16,600 --> 00:12:21,620 of information technology, how we're going to transfer all that data between different 158 00:12:21,620 --> 00:12:28,660 blood centers, different hospital sites, and then having patient data on one side, donor 159 00:12:28,660 --> 00:12:30,440 data on the other side. 160 00:12:30,440 --> 00:12:31,800 It's pretty complex. 161 00:12:31,800 --> 00:12:34,380 So we've taken in baby steps to be realistic. 162 00:12:34,380 --> 00:12:39,900 We didn't go from, oh, this is important to let's try to get this directly in the clinic. 163 00:12:39,900 --> 00:12:47,360 But I think in the end, I hope that within my career that this is going to be something 164 00:12:47,360 --> 00:12:52,100 that's going to be available for patients because I think there's advances that are 165 00:12:52,100 --> 00:12:58,420 being made outside of the work that we're doing, which will allow methods that will 166 00:12:58,420 --> 00:13:02,580 allow us to sequence at a much more cost effective way. 167 00:13:02,580 --> 00:13:06,780 There's probably going to be other work that's done. 168 00:13:06,780 --> 00:13:15,380 For instance, there's a national group through the DHHS who's looking at an antibody registry 169 00:13:15,380 --> 00:13:18,220 for hospitals to report their antibodies. 170 00:13:18,220 --> 00:13:23,020 So in that sense, it's like trying to find a way where there's going to be a method to 171 00:13:23,020 --> 00:13:29,580 communicate information from different hospital sites about transfusion data, and that potentially 172 00:13:29,580 --> 00:13:33,580 would help be a platform for anything we would want to do in the future. 173 00:13:33,580 --> 00:13:39,260 So I think melding things that are things that you work on, but knowing what everybody 174 00:13:39,260 --> 00:13:42,740 else is working on and seeing how that might help. 175 00:13:42,740 --> 00:13:44,660 I feel like I've gotten way far off. 176 00:13:44,660 --> 00:13:47,980 You can try to bring it back. 177 00:13:47,980 --> 00:13:51,940 No, actually, I feel like you did a great job of just kind of... 178 00:13:51,940 --> 00:13:57,400 First of all, I think one of the things you did was go to a 30,000 foot view and talk 179 00:13:57,400 --> 00:14:00,380 to us about how this is big picture. 180 00:14:00,380 --> 00:14:01,500 There's so much going on. 181 00:14:01,500 --> 00:14:02,500 It's very complicated. 182 00:14:02,500 --> 00:14:07,900 And what you succeeded in doing is taking something that's a small piece of it and then 183 00:14:07,900 --> 00:14:10,900 just advancing it just a little step at a time. 184 00:14:10,900 --> 00:14:15,820 And even now, you are doing kind of collaborative projects even between centers and talking 185 00:14:15,820 --> 00:14:17,660 about how that gets bigger. 186 00:14:17,660 --> 00:14:20,980 Multiple centers will need to be involved, multiple blood centers. 187 00:14:20,980 --> 00:14:25,220 And I think what you're talking about is just the cascading effect of the work that we do 188 00:14:25,220 --> 00:14:27,740 when we start small and not expecting... 189 00:14:27,740 --> 00:14:32,180 Because many times, and Stella, you're senior enough that people look to you and they're 190 00:14:32,180 --> 00:14:33,700 like, oh my gosh, she's so successful. 191 00:14:33,700 --> 00:14:35,580 Look at all the awesome stuff she's doing. 192 00:14:35,580 --> 00:14:40,420 And what people miss is the baby steps that you took when you first started and the fact 193 00:14:40,420 --> 00:14:44,180 that you still are taking baby steps and that's what's moving you forward. 194 00:14:44,180 --> 00:14:47,340 And I think it's important that people recognize that. 195 00:14:47,340 --> 00:14:51,900 I think the other thing I love that you said at the very beginning is you talked about 196 00:14:51,900 --> 00:14:54,780 collaboration, but you didn't start with mentors. 197 00:14:54,780 --> 00:14:57,980 You started with those around you immediately. 198 00:14:57,980 --> 00:15:01,100 And I feel like you talked about your trainees in the lab. 199 00:15:01,100 --> 00:15:03,260 You talked about the research assistants. 200 00:15:03,260 --> 00:15:06,860 You talked about choosing specialized mentors carefully. 201 00:15:06,860 --> 00:15:11,700 And I really love that because sometimes I think there's a sense from, I think especially 202 00:15:11,700 --> 00:15:15,760 people who are just starting out, that there is one mentor, one senior person who's going 203 00:15:15,760 --> 00:15:19,580 to open the door and all things are going to fall in place. 204 00:15:19,580 --> 00:15:23,500 And I think many people are disappointed when they find that that doesn't happen. 205 00:15:23,500 --> 00:15:28,180 And I love that you started really with the reality of starting with who's around you, 206 00:15:28,180 --> 00:15:30,540 who's immediately available to help you. 207 00:15:30,540 --> 00:15:34,620 And when you look ahead to those who've gone far ahead, it's like who is specifically suited 208 00:15:34,620 --> 00:15:39,740 to help you, not just because of their expertise, but actually having the time and the interest 209 00:15:39,740 --> 00:15:40,740 to help you. 210 00:15:40,740 --> 00:15:42,720 So I love that you put so many things together. 211 00:15:42,720 --> 00:15:46,980 And I wonder if you want to speak to the whole piece of mentorship and how that plays a role 212 00:15:46,980 --> 00:15:47,980 in your advancement. 213 00:15:47,980 --> 00:15:54,680 I mean, certainly, I think I was also really fortunate because I had multiple mentors in 214 00:15:54,680 --> 00:15:55,680 my early career. 215 00:15:55,680 --> 00:16:03,020 So I chose to work at Mitch Weiss's lab and he was my primary mentor and he was a phenomenal 216 00:16:03,020 --> 00:16:04,020 mentor. 217 00:16:04,020 --> 00:16:05,300 He was a great manager in the lab. 218 00:16:05,300 --> 00:16:10,780 He thought it was fun to come into the lab and show me how to do things like literally 219 00:16:10,780 --> 00:16:12,180 hands on. 220 00:16:12,180 --> 00:16:16,540 But at the same time, he was more than just an academic mentor. 221 00:16:16,540 --> 00:16:22,940 I think he is one of the few men who I have seen in science who really partnered with 222 00:16:22,940 --> 00:16:25,420 his wife, who is also a physician scientist. 223 00:16:25,420 --> 00:16:32,100 And I always found it refreshing to see his contributions to their family. 224 00:16:32,100 --> 00:16:35,900 So he would sometimes just have a hard stop at five o'clock because he was the one who 225 00:16:35,900 --> 00:16:39,120 was responsible to pick up his children from daycare. 226 00:16:39,120 --> 00:16:48,140 So I think his way of just balancing work and life as well was important to me. 227 00:16:48,140 --> 00:16:50,080 But he was also a sponsor. 228 00:16:50,080 --> 00:16:55,980 So I think one of the things that I always tell trainees that I interact with now is 229 00:16:55,980 --> 00:16:59,820 that you really have to find something that you love doing. 230 00:16:59,820 --> 00:17:04,740 And like you said, looking back now, I went through a period in his lab where I said, 231 00:17:04,740 --> 00:17:08,620 I'm going to finish my project and then I'm going to move on. 232 00:17:08,620 --> 00:17:13,060 So I came to his lab without any basic lab research experience. 233 00:17:13,060 --> 00:17:16,820 I picked up a pipette the first time coming to his lab. 234 00:17:16,820 --> 00:17:21,580 And I didn't think that that was where my career was going. 235 00:17:21,580 --> 00:17:26,860 I wanted it for the experience, but not necessarily to run my own lab. 236 00:17:26,860 --> 00:17:31,740 And I would say that finishing fellowship, I thought that I was going to finish my project 237 00:17:31,740 --> 00:17:33,340 and move on. 238 00:17:33,340 --> 00:17:37,220 And he said, you have to do what makes you happy. 239 00:17:37,220 --> 00:17:42,380 If this is not what makes you happy, then you should choose to move on. 240 00:17:42,380 --> 00:17:47,340 And I thought that at the time I would get a master's in clinical epidemiology next and 241 00:17:47,340 --> 00:17:50,500 move on to really more clinical research. 242 00:17:50,500 --> 00:17:56,660 But as it happened, just other forces that were happening in my life and being married 243 00:17:56,660 --> 00:18:02,180 also to a physician and having two people that would need the right choice of an institution 244 00:18:02,180 --> 00:18:05,060 in their next career steps, we stayed here. 245 00:18:05,060 --> 00:18:08,500 And that was one of the reasons why I ended up doing the transfusion medicine fellowship 246 00:18:08,500 --> 00:18:10,380 a few years later. 247 00:18:10,380 --> 00:18:14,820 But I think just finding what makes you happy is what's really important. 248 00:18:14,820 --> 00:18:16,660 And sometimes it's a little transition period. 249 00:18:16,660 --> 00:18:20,380 So I will admit, I wrote my KOE. 250 00:18:20,380 --> 00:18:25,260 And I thought, in my mind, I'm not exactly sure why I'm writing my KOE because I'm not 251 00:18:25,260 --> 00:18:26,860 really going to be doing this anymore. 252 00:18:26,860 --> 00:18:28,600 But I wrote it and then I got it. 253 00:18:28,600 --> 00:18:30,780 So then I stayed in the lab for a few more years. 254 00:18:30,780 --> 00:18:37,580 And I think really what happened was it took time to gain more skills and gain more confidence 255 00:18:37,580 --> 00:18:43,300 in the lab, which I did not have initially because I did not have a PhD prior to my lab 256 00:18:43,300 --> 00:18:44,300 experience. 257 00:18:44,300 --> 00:18:50,420 And then I think what really catches you is you actually discover something and just the 258 00:18:50,420 --> 00:18:58,380 satisfaction and the joy you get of discovering something, having a body of work that you 259 00:18:58,380 --> 00:19:01,500 publish is quite satisfying. 260 00:19:01,500 --> 00:19:06,140 And I think that's probably what hooked me was the high you get off of that. 261 00:19:06,140 --> 00:19:15,300 So I still do think of Mitch as a mentor, a sponsor, a friend, a colleague. 262 00:19:15,300 --> 00:19:19,620 She's been a wonderful person in my life. 263 00:19:19,620 --> 00:19:24,020 I also was really lucky that through him, actually, I met Connie Westhoff, who is a 264 00:19:24,020 --> 00:19:30,060 giant in the field of transfusion medicine and R.H. genetics, and she too was also a 265 00:19:30,060 --> 00:19:32,700 mentor and a sponsor. 266 00:19:32,700 --> 00:19:34,660 And obviously we still collaborate. 267 00:19:34,660 --> 00:19:40,820 And even as she is moving on, probably in the next few years, she's slowly trying to 268 00:19:40,820 --> 00:19:42,340 take on retirement. 269 00:19:42,340 --> 00:19:49,020 I still go to her all the time because she has this wealth of knowledge, which I'm convinced 270 00:19:49,020 --> 00:19:57,780 nobody else on the planet Earth has besides her, but she was also a wonderful mentor and 271 00:19:57,780 --> 00:19:59,780 career advocate for me. 272 00:19:59,780 --> 00:20:05,500 And then I also had to mention Katie Mano, who was my clinical mentor in hematology. 273 00:20:05,500 --> 00:20:12,100 And she's the one who actually provided the opportunity of considering a transfusion medicine 274 00:20:12,100 --> 00:20:13,100 fellowship. 275 00:20:13,100 --> 00:20:20,740 And I think at the time, looking from her point of view, she saw it as a place where 276 00:20:20,740 --> 00:20:25,660 Chopp could probably use another person who was well versed in both hematology and transfusion 277 00:20:25,660 --> 00:20:27,180 medicine. 278 00:20:27,180 --> 00:20:32,540 And she probably just saw certain things in me that seemed like that would be a good fit 279 00:20:32,540 --> 00:20:33,540 for me. 280 00:20:33,540 --> 00:20:35,540 And she was super duper right. 281 00:20:35,540 --> 00:20:42,540 So I think just having, I've just been really lucky to have people in my career who have 282 00:20:42,540 --> 00:20:44,800 helped me find that opportunity. 283 00:20:44,800 --> 00:20:49,340 And partly, I think because they've taken the time to get to know me and really know 284 00:20:49,340 --> 00:20:54,460 me to help me choose the right pathway. 285 00:20:54,460 --> 00:20:55,460 I love it. 286 00:20:55,460 --> 00:20:56,620 I love it. 287 00:20:56,620 --> 00:21:01,260 One of the things that really resonates with me as you're sharing is that you really had 288 00:21:01,260 --> 00:21:05,100 multiple relationships that were instrumental in your forward motion. 289 00:21:05,100 --> 00:21:11,420 And it was mentoring relationships, but it was also the intersection between what's going 290 00:21:11,420 --> 00:21:16,420 on in your career, what was going on in your personal life and making things work. 291 00:21:16,420 --> 00:21:22,980 And so ultimately, I think what I'm hearing you also say is just how you have to look 292 00:21:22,980 --> 00:21:27,860 at everything in the context of your life, also in the context of what you enjoy doing, 293 00:21:27,860 --> 00:21:31,640 and then see what opportunities make the most sense for you. 294 00:21:31,640 --> 00:21:35,680 So then I'm almost hearing you say there's no cookie cutter way forward, and there is 295 00:21:35,680 --> 00:21:42,100 no one person or one thing that is in charge of moving everything forward. 296 00:21:42,100 --> 00:21:48,160 It's just really integrating all the experiences that you're having to pick the thing that 297 00:21:48,160 --> 00:21:50,200 makes the most sense to move forward in. 298 00:21:50,200 --> 00:21:51,200 Is that fair to say? 299 00:21:51,200 --> 00:21:52,200 Exactly. 300 00:21:52,200 --> 00:21:53,200 Yep. 301 00:21:53,200 --> 00:21:54,200 That's what I tried to convey to you. 302 00:21:54,200 --> 00:21:55,200 Yeah. 303 00:21:55,200 --> 00:21:56,200 Now I like it. 304 00:21:56,200 --> 00:22:00,920 I love it because I think it's that we are, we're hard workers as clinicians. 305 00:22:00,920 --> 00:22:06,480 I don't think that's anything that has to be said, but just even as we work hard, seeing 306 00:22:06,480 --> 00:22:10,820 what opportunities arise and not feeling like there has to be just one way, because then 307 00:22:10,820 --> 00:22:13,780 I think we could be disappointed. 308 00:22:13,780 --> 00:22:16,100 Which brings me to what you talked about, success. 309 00:22:16,100 --> 00:22:17,260 Let's talk about success. 310 00:22:17,260 --> 00:22:23,780 So what were you referring to when you talked about the different definitions of success? 311 00:22:23,780 --> 00:22:31,700 Well, I think how you define success, even just in the realm of say a clinician researcher, 312 00:22:31,700 --> 00:22:38,380 some might define success because they get promoted or they publish in a really high 313 00:22:38,380 --> 00:22:40,260 impact journal. 314 00:22:40,260 --> 00:22:48,580 For me, success is, I think success is doing every day what I truly love. 315 00:22:48,580 --> 00:22:54,380 I wake up in the morning and I think about what I'm going to try to tackle in a day and 316 00:22:54,380 --> 00:23:00,380 you never get it all done, but you just have that motivation every day to go to work and 317 00:23:00,380 --> 00:23:02,580 get something accomplished. 318 00:23:02,580 --> 00:23:08,820 I think for me, the thing that's been the most meaningful is seeing, again, we're taking 319 00:23:08,820 --> 00:23:15,260 baby steps, but seeing how some of the work that we do actually impacts patient care and 320 00:23:15,260 --> 00:23:21,740 seeing that we're moving the needle slowly, but we're moving the needle. 321 00:23:21,740 --> 00:23:29,300 I think for me, knowing that what we do every day in the lab or in our clinical research 322 00:23:29,300 --> 00:23:36,460 studies, there's going to be an outcome that actually matters is how I define success. 323 00:23:36,460 --> 00:23:42,380 Whereas on the other side, we do some pretty basic stuff in the lab and sometimes we're 324 00:23:42,380 --> 00:23:43,380 successful too. 325 00:23:43,380 --> 00:23:49,100 We figure out what are proteins doing or we have a certain hypothesis and we're right 326 00:23:49,100 --> 00:23:51,140 in our hypothesis. 327 00:23:51,140 --> 00:23:58,300 That's satisfying also, but to me, that's less satisfying than knowing that the work 328 00:23:58,300 --> 00:24:02,460 we do can impact patient care or patient outcomes. 329 00:24:02,460 --> 00:24:07,740 I think that's the part that drives me the most and probably because I think I'm a clinician 330 00:24:07,740 --> 00:24:15,380 at heart and the questions I ask and the questions I tried to answer for myself are really clinical 331 00:24:15,380 --> 00:24:19,020 questions at the heart, but just using different tools. 332 00:24:19,020 --> 00:24:20,340 Absolutely. 333 00:24:20,340 --> 00:24:25,220 I feel like you speak to a lot of perspectives of clinicians because ultimately for many 334 00:24:25,220 --> 00:24:30,420 of us, we started out as clinicians first and then we made this transition to research. 335 00:24:30,420 --> 00:24:35,580 Really at the heart of our clinical heart is making things better for patients. 336 00:24:35,580 --> 00:24:40,660 I hear you speak about the opportunities you have to make an impact in the lives of patients 337 00:24:40,660 --> 00:24:44,940 and seeing your research turn into that is very satisfying for you. 338 00:24:44,940 --> 00:24:51,180 I also hear you talking about success as success and enjoying every day, success and enjoying 339 00:24:51,180 --> 00:24:52,620 your journey. 340 00:24:52,620 --> 00:24:58,180 Not looking for the end goal, though you have a lot of wonderful things that you've accomplished 341 00:24:58,180 --> 00:24:59,620 over the course of your career. 342 00:24:59,620 --> 00:25:04,020 You've gotten those things too, but not looking at those items as the things that define you 343 00:25:04,020 --> 00:25:06,740 as successful, but the fact that you're making an impact. 344 00:25:06,740 --> 00:25:09,100 You're doing work that you find meaningful. 345 00:25:09,100 --> 00:25:10,240 You're doing it every day. 346 00:25:10,240 --> 00:25:14,820 You're making discoveries that are interesting and important to you. 347 00:25:14,820 --> 00:25:18,820 I'm just hearing the threat of personal daily satisfaction. 348 00:25:18,820 --> 00:25:19,820 Yeah. 349 00:25:19,820 --> 00:25:26,580 I think that's what's really important because otherwise it'd be really hard to do our jobs 350 00:25:26,580 --> 00:25:31,180 where we're pulled in so many different directions and we have so many different responsibilities 351 00:25:31,180 --> 00:25:40,020 and we're just trying to always do our best in each of the different arenas, but we know 352 00:25:40,020 --> 00:25:43,100 that that's always challenging. 353 00:25:43,100 --> 00:25:44,100 It is. 354 00:25:44,100 --> 00:25:45,100 It is. 355 00:25:45,100 --> 00:25:47,340 And something that you didn't say that I feel like is part of the theme of what you're saying 356 00:25:47,340 --> 00:25:51,740 is you can't live somebody else's dream because that's very hard to do. 357 00:25:51,740 --> 00:25:56,060 And the fact that you're living your own dream allows you to manage all the challenges that 358 00:25:56,060 --> 00:25:59,980 are surrounding it and still move things forward. 359 00:25:59,980 --> 00:26:03,020 I don't know if you want to speak a little bit about that. 360 00:26:03,020 --> 00:26:06,780 I think the way I see it is I prioritize things. 361 00:26:06,780 --> 00:26:16,980 So I see sometimes I prioritize based on what I feel like I need to do versus what other 362 00:26:16,980 --> 00:26:18,180 people can do. 363 00:26:18,180 --> 00:26:27,460 So I could volunteer to say cover another clinic or something, but would that really 364 00:26:27,460 --> 00:26:32,780 be the best use of my time or would I contribute the most to us as a group? 365 00:26:32,780 --> 00:26:34,440 And that's probably no. 366 00:26:34,440 --> 00:26:39,360 But there are other things that I know I can do. 367 00:26:39,360 --> 00:26:44,300 So for instance, somebody asked me to look at their specific aims page for their K award 368 00:26:44,300 --> 00:26:49,060 and I know that's particularly important that I could potentially give them feedback at 369 00:26:49,060 --> 00:26:55,980 this stage where they still have a month to do it and I prioritize that much higher. 370 00:26:55,980 --> 00:27:00,740 So I think you really have to prioritize what's really important. 371 00:27:00,740 --> 00:27:05,420 I think one of the challenges we all have these days is that there seems to be a lot 372 00:27:05,420 --> 00:27:08,700 of tasks that we all have to do. 373 00:27:08,700 --> 00:27:16,540 There's endless emails about things that you need to fill out or do and it can be onerous 374 00:27:16,540 --> 00:27:17,900 to get all those things done. 375 00:27:17,900 --> 00:27:24,380 But I think prioritizing them and then seeing where you can delegate things or seeing where 376 00:27:24,380 --> 00:27:31,380 you can do something quickly rather than spend too much time on it helps me at least manage 377 00:27:31,380 --> 00:27:36,380 the day to day so that I get to spend time on things that I think are what's really important 378 00:27:36,380 --> 00:27:41,900 and what I really want to do so that you don't get overwhelmed by all that other task-oriented 379 00:27:41,900 --> 00:27:44,460 work that we oftentimes have. 380 00:27:44,460 --> 00:27:46,460 I love it. 381 00:27:46,460 --> 00:27:52,220 I found that I think you gave us some kind of organization of type gems in all of that. 382 00:27:52,220 --> 00:27:54,340 One you talk about working in your zone of genius. 383 00:27:54,340 --> 00:27:58,380 So there are many things you can do but what are the things that you are uniquely qualified 384 00:27:58,380 --> 00:28:00,860 to do that you actually like to do? 385 00:28:00,860 --> 00:28:04,380 Another thing is recognizing that while everything needs to get done, everything doesn't need 386 00:28:04,380 --> 00:28:05,980 to get done equally well. 387 00:28:05,980 --> 00:28:11,100 And what are the things that you can drop your standards on but still get done? 388 00:28:11,100 --> 00:28:14,260 And what are the things that you absolutely need to focus on? 389 00:28:14,260 --> 00:28:18,580 And then one thing you said also that I really, really, really, I don't know, it gets me excited 390 00:28:18,580 --> 00:28:21,700 to think about is moving your work forward. 391 00:28:21,700 --> 00:28:26,660 And that's so important because if you don't move your work forward, nobody else will. 392 00:28:26,660 --> 00:28:30,660 And other work needs to be moved forward and you surely do need to be part of that as a 393 00:28:30,660 --> 00:28:32,260 collaborative person. 394 00:28:32,260 --> 00:28:38,260 But prioritizing the work that really means a lot to you, really moves your career forward 395 00:28:38,260 --> 00:28:39,260 is important. 396 00:28:39,260 --> 00:28:45,520 And I do think that many of us early on always think about, well, how do we satisfy the needs 397 00:28:45,520 --> 00:28:46,520 of everybody else? 398 00:28:46,520 --> 00:28:50,100 And then at the end of the day, we hope there's time to move our work forward. 399 00:28:50,100 --> 00:28:52,500 It's really our work comes first. 400 00:28:52,500 --> 00:28:56,900 And then we find time later to move other people's work forward as well. 401 00:28:56,900 --> 00:28:57,900 Right. 402 00:28:57,900 --> 00:29:03,860 And I think it's particularly true because there aren't too many of us that practice 403 00:29:03,860 --> 00:29:10,140 hematology, transfusion medicine, and then have a particular skill set. 404 00:29:10,140 --> 00:29:17,580 So for instance, we had a project where we were making in-vitro derived red cells from 405 00:29:17,580 --> 00:29:24,380 induced cloripotent stem cells that we genetically engineered to have specific Rh variants or 406 00:29:24,380 --> 00:29:26,580 Rh null. 407 00:29:26,580 --> 00:29:33,900 And I think what was special about that project was that I was sort of like a matchmaker in 408 00:29:33,900 --> 00:29:38,540 the sense that we had Connie Westhoff from the New York Blood Center who's like an Rh 409 00:29:38,540 --> 00:29:44,820 expert and we had Gordon Keller from Canada who's an expert in developmental hematopoiesis 410 00:29:44,820 --> 00:29:54,100 and cloripotent stem cells and Jim Pallas at Rochester who also really understands developmental 411 00:29:54,100 --> 00:29:55,760 red cell development. 412 00:29:55,760 --> 00:29:57,300 And then we had people from CHOP. 413 00:29:57,300 --> 00:30:03,420 So Paul Gaudu and Dina French who are long time collaborators at CHOP who work mostly 414 00:30:03,420 --> 00:30:05,260 on iPS cells. 415 00:30:05,260 --> 00:30:11,740 But bringing all of that different expertise to put together in this project was very unique 416 00:30:11,740 --> 00:30:17,980 because it was like little pieces of the puzzle and getting it all together. 417 00:30:17,980 --> 00:30:23,700 And we're so far from, you know, that's another goal of mine is by the end of my career, I'd 418 00:30:23,700 --> 00:30:29,540 like to know that that work went somewhere where, you know, it's actually in the blood 419 00:30:29,540 --> 00:30:30,540 bank. 420 00:30:30,540 --> 00:30:34,180 We actually have reagents that we developed in the blood bank helping us to facilitate 421 00:30:34,180 --> 00:30:36,500 antibody identification. 422 00:30:36,500 --> 00:30:42,300 Or maybe, you know, and this is probably a much higher goal, is that we see the Rh null 423 00:30:42,300 --> 00:30:48,460 cells that we created actually get to a place where we can make an ass that they can be 424 00:30:48,460 --> 00:30:49,460 used. 425 00:30:49,460 --> 00:30:53,180 I don't know for transfusion unless we're going to transfuse neonates with them, but 426 00:30:53,180 --> 00:30:58,780 as like a drug carrier or something where you use it for immune modulation, but something 427 00:30:58,780 --> 00:30:59,980 in the clinic. 428 00:30:59,980 --> 00:31:01,900 And I think it has like a certain utility. 429 00:31:01,900 --> 00:31:07,600 I think, again, it's there's so many aspects of it, which we're good at some of those aspects. 430 00:31:07,600 --> 00:31:12,660 And I'm still looking for, you know, collaborators to help with some of the other aspects of 431 00:31:12,660 --> 00:31:14,580 making it a reality. 432 00:31:14,580 --> 00:31:20,820 But it's, again, bringing together all these different people that have different expertise 433 00:31:20,820 --> 00:31:25,540 is one of the most enjoyable parts, I think, of the work that we do. 434 00:31:25,540 --> 00:31:27,260 I love it. 435 00:31:27,260 --> 00:31:30,260 It's I love how you use the term matchmaker. 436 00:31:30,260 --> 00:31:34,660 It's recognizing where you're strong and where you're not strong, and then looking around 437 00:31:34,660 --> 00:31:39,340 to see who are the people in your network that can fill the gaps. 438 00:31:39,340 --> 00:31:43,100 And even if they're not in your network, you know, how do you expand your networks to fill 439 00:31:43,100 --> 00:31:47,540 gaps that allow your work to move forward because you can't do it by yourself. 440 00:31:47,540 --> 00:31:50,100 So really speaking to the power of collaboration. 441 00:31:50,100 --> 00:31:51,820 Yeah, that's that's really awesome. 442 00:31:51,820 --> 00:31:55,600 Well, Stella, we're coming to the end of this time. 443 00:31:55,600 --> 00:32:00,580 And I really want you, if you could just, you know, speaking to someone who let's say 444 00:32:00,580 --> 00:32:05,180 we have a clinician who's in their early fellowship years, they're like, well, I've never picked 445 00:32:05,180 --> 00:32:06,180 up a pipette. 446 00:32:06,180 --> 00:32:08,780 I have no idea how I would contribute. 447 00:32:08,780 --> 00:32:12,260 I don't even know that I could be successful as a scientist. 448 00:32:12,260 --> 00:32:13,260 What would you say to them? 449 00:32:13,260 --> 00:32:16,980 I would say they 100% could do it. 450 00:32:16,980 --> 00:32:23,220 I think if you've gotten to this part of your career, you are motivated and intelligent 451 00:32:23,220 --> 00:32:29,900 enough to pick up a pipette in your early 30s and you have many, many more decades to 452 00:32:29,900 --> 00:32:30,900 come. 453 00:32:30,900 --> 00:32:32,460 So I think they can definitely do it. 454 00:32:32,460 --> 00:32:39,580 I think, again, probably choosing the right project and the right mentor is, of course, 455 00:32:39,580 --> 00:32:40,580 critical. 456 00:32:40,580 --> 00:32:46,460 So choose a project that, you know, sparks a real interest to you and choose a mentor 457 00:32:46,460 --> 00:32:48,820 who you really think you're going to connect with. 458 00:32:48,820 --> 00:32:54,660 So I think, you know, you have to find a mentor who will have the time to mentor you, who 459 00:32:54,660 --> 00:32:56,140 has experience mentoring. 460 00:32:56,140 --> 00:33:02,420 But ultimately, I think just knowing if the two of you connect on a personal level, I 461 00:33:02,420 --> 00:33:08,380 think really matters because that person should be someone you spent a lot of time with and 462 00:33:08,380 --> 00:33:14,300 who you're going to spend time with for probably the duration of your career, I think, if they're 463 00:33:14,300 --> 00:33:16,140 a good mentor. 464 00:33:16,140 --> 00:33:19,100 So that's a really important aspect. 465 00:33:19,100 --> 00:33:20,100 Absolutely. 466 00:33:20,100 --> 00:33:21,100 Absolutely. 467 00:33:21,100 --> 00:33:25,100 And Stella, if you don't mind, what about someone who says, holy cow, I owe so much 468 00:33:25,100 --> 00:33:26,100 money. 469 00:33:26,100 --> 00:33:30,420 Like, is this a viable career? 470 00:33:30,420 --> 00:33:31,420 I think so. 471 00:33:31,420 --> 00:33:37,460 And I think that recently there has actually been more programs that will pay for your 472 00:33:37,460 --> 00:33:41,540 educational expenses, at least for medical school in that sense. 473 00:33:41,540 --> 00:33:47,940 I was lucky because I had all of my med school loans essentially paid for by the NIH because 474 00:33:47,940 --> 00:33:48,980 I stayed in research. 475 00:33:48,980 --> 00:33:55,060 And that wasn't the reason why I stayed in research, but there are those opportunities. 476 00:33:55,060 --> 00:34:01,060 And I think in the end, we do come out with a fair amount of debt when you go to medical 477 00:34:01,060 --> 00:34:02,060 school. 478 00:34:02,060 --> 00:34:07,140 But I think that over time, you pay that down. 479 00:34:07,140 --> 00:34:14,860 And I think in general, we make a significant enough salary that you should choose to do 480 00:34:14,860 --> 00:34:20,620 something you really want to do and not worry about the debt because it will over time seem 481 00:34:20,620 --> 00:34:22,580 like a smaller and smaller issue. 482 00:34:22,580 --> 00:34:24,020 Thank you, Stella. 483 00:34:24,020 --> 00:34:26,620 I really appreciate you speaking to that. 484 00:34:26,620 --> 00:34:29,700 So everyone, you heard Dr. Chow. 485 00:34:29,700 --> 00:34:33,120 Don't let debt be the driving factor for your career decision. 486 00:34:33,120 --> 00:34:37,200 You want to do something you love and then you figure out how to make everything else 487 00:34:37,200 --> 00:34:38,940 work and it will work. 488 00:34:38,940 --> 00:34:39,940 You can make it happen. 489 00:34:39,940 --> 00:34:41,100 You're an innovative person. 490 00:34:41,100 --> 00:34:43,260 You've come this far in your career. 491 00:34:43,260 --> 00:34:44,880 You can make hard things happen. 492 00:34:44,880 --> 00:34:49,980 So definitely if you want to consider this career or you're in the process and think 493 00:34:49,980 --> 00:34:52,260 you have quitting, don't quit. 494 00:34:52,260 --> 00:34:54,300 You have the capacity to succeed. 495 00:34:54,300 --> 00:34:56,540 So Stella, I want to thank you for being on the show. 496 00:34:56,540 --> 00:34:58,200 Thank you for your words of wisdom. 497 00:34:58,200 --> 00:35:01,180 And it just was a fantastic, fantastic time. 498 00:35:01,180 --> 00:35:03,100 And I want to thank you for your time. 499 00:35:03,100 --> 00:35:04,100 Thanks for the invitation. 500 00:35:04,100 --> 00:35:05,100 All right, everyone. 501 00:35:05,100 --> 00:35:16,620 We'll see you next time on the Clinician Researcher Podcast. 502 00:35:16,620 --> 00:35:21,980 Thanks for listening to this episode of the Clinician Researcher Podcast where academic 503 00:35:21,980 --> 00:35:27,300 clinicians learn the skills to build their own research program, whether or not they 504 00:35:27,300 --> 00:35:28,780 have a mentor. 505 00:35:28,780 --> 00:35:34,740 If you found the information in this episode to be helpful, don't keep it all to yourself. 506 00:35:34,740 --> 00:35:36,620 Someone else needs to hear it. 507 00:35:36,620 --> 00:35:40,680 So take a minute right now and share it. 508 00:35:40,680 --> 00:35:46,140 As you share this episode, you become part of our mission to help launch a new generation 509 00:35:46,140 --> 00:35:59,660 of clinician researchers who make transformative discoveries that change the way we do health

Stella Chou Profile Photo

Stella Chou

Dr. Stella Chou is an Associate Professor of Pediatrics at the Perelman School of Medicine at the University of Pennsylvania and Chief of the Division of Transfusion Medicine at The Children's Hospital of Philadelphia. She practices both Pediatric Hematology and Transfusion Medicine with particular interests in pediatric hematologic disorders. Her laboratory uses induced pluripotent stem cells to model pediatric blood diseases including those associated with Down Syndrome. In the transfusion medicine arena, her work has demonstrated that inheritance of variant RH contributes to Rh alloimmunization. Ongoing work focuses on RH genetic matching of red cells, integrating molecular technologies into clinical transfusion medicine practice and developing novel tools for blood banks including induced pluripotent stem cell (iPSC) derived red cells with rare blood group antigen combinations. Her goal is to identify new approaches to minimize alloimmunization, reduce complications and improve therapy.